Zeria Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zeria Pharmaceutical Co Ltd with three other
companies in this sector in Japan:
Fuso Pharmaceutical Industries Ltd
sales of 47.04 billion Japanese Yen [US$395.15 million]
Aska Pharmaceutical Company Limited
(42.91 billion Japanese Yen [US$360.42 million]
Towa Pharmaceutical Company Limited
(71.47 billion Japanese Yen [US$600.35 million]
of which 100%
was Pharmaceutical Business).
Zeria Pharmaceutical Co Ltd reported sales of ¥61.01 billion (US$512.51 million)
March of 2015.
decrease of 1.6%
versus 2014, when the company's sales were ¥62.00 billion.
Contributing to the drop in overall sales was the 10.6% decline
in Other, from ¥176.70 million to ¥157.96 million.
There were also decreases in sales in
Pharmaceuticals Business (down 7.3% to ¥33.76 billion)
However, these declines were partially offset by the increase in sales of
Consumer Healthcare Business (up 6.7% to ¥27.10 billion)